{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:35:19Z","timestamp":1790534119171,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ymthe.2021.02.018","type":"journal-article","created":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:26:57Z","timestamp":1613435217000},"page":"2108-2120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["USP22 deficiency in melanoma mediates resistance to T\u00a0cells through IFN\u03b3-JAK1-STAT1 signal axis"],"prefix":"10.1016","volume":"29","author":[{"given":"Min","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanlin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3261-8206","authenticated-orcid":false,"given":"Xuanming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2021.02.018_bib1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.02.018_bib2","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2021.02.018_bib3","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJMoa1712126","article-title":"Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma","volume":"378","author":"Motzer","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2021.02.018_bib4","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1801946","article-title":"Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden","volume":"378","author":"Hellmann","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2021.02.018_bib5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-med-092012-112807","article-title":"Immune modulation in cancer with antibodies","volume":"65","author":"Page","year":"2014","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ymthe.2021.02.018_bib6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature23270","article-title":"In\u00a0vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target","volume":"547","author":"Manguso","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.02.018_bib7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3389\/fimmu.2019.00251","article-title":"Genome-Wide CRISPR Screening Identifies JAK1 Deficiency as a Mechanism of T-Cell Resistance","volume":"10","author":"Han","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2021.02.018_bib8","doi-asserted-by":"crossref","first-page":"7090","DOI":"10.1182\/blood-2010-10-314286","article-title":"PTPN2 negatively regulates oncogenic JAK1 in T-cell acute lymphoblastic leukemia","volume":"117","author":"Kleppe","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2021.02.018_bib9","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/ng.587","article-title":"Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia","volume":"42","author":"Kleppe","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2021.02.018_bib10","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.cell.2005.11.007","article-title":"A genomic and functional inventory of deubiquitinating enzymes","volume":"123","author":"Nijman","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2021.02.018_bib11","doi-asserted-by":"crossref","first-page":"T19","DOI":"10.1530\/ERC-14-0185","article-title":"Histone H2B monoubiquitination: roles to play in human malignancy","volume":"22","author":"Cole","year":"2015","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.ymthe.2021.02.018_bib12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.molcel.2007.12.015","article-title":"The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression","volume":"29","author":"Zhang","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymthe.2021.02.018_bib13","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1128\/MCB.00971-12","article-title":"A high-confidence interaction map identifies SIRT1 as a mediator of acetylation of USP22 and the SAGA coactivator complex","volume":"33","author":"Armour","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ymthe.2021.02.018_bib14","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1159\/000362964","article-title":"Ubiquitin-specific peptidase USP22 negatively regulates the STAT signaling pathway by deubiquitinating SIRT1","volume":"33","author":"Ao","year":"2014","journal-title":"Cell. Physiol. Biochem"},{"key":"10.1016\/j.ymthe.2021.02.018_bib15","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.molcel.2012.03.024","article-title":"USP22 antagonizes p53 transcriptional activation by deubiquitinating Sirt1 to suppress cell apoptosis and is required for mouse embryonic development","volume":"46","author":"Lin","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymthe.2021.02.018_bib16","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1172\/JCI97831","article-title":"G\u03b112 ablation exacerbates liver steatosis and obesity by suppressing USP22\/SIRT1-regulated mitochondrial respiration","volume":"128","author":"Kim","year":"2018","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2021.02.018_bib17","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.stem.2014.08.001","article-title":"SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug resistance of human FLT3-ITD acute myeloid leukemia stem cells","volume":"15","author":"Li","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2021.02.018_bib18","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1172\/JCI23412","article-title":"Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer","volume":"115","author":"Glinsky","year":"2005","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2021.02.018_bib19","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.4161\/cc.5.11.2796","volume":"5","author":"Glinsky","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ymthe.2021.02.018_bib20","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.2147\/OTT.S148662","article-title":"High expression of USP22 predicts poor prognosis and advanced clinicopathological features in solid tumors: a meta-analysis","volume":"11","author":"Yang","year":"2018","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ymthe.2021.02.018_bib21","doi-asserted-by":"crossref","first-page":"12654","DOI":"10.18632\/oncotarget.3705","article-title":"High USP22 expression indicates poor prognosis in hepatocellular carcinoma","volume":"6","author":"Tang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ymthe.2021.02.018_bib22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.trsl.2014.09.005","article-title":"Ubiquitin-specific peptidase 22 overexpression may promote cancer progression and poor prognosis in human gastric carcinoma","volume":"165","author":"He","year":"2015","journal-title":"Transl. Res."},{"key":"10.1016\/j.ymthe.2021.02.018_bib23","doi-asserted-by":"crossref","first-page":"15028","DOI":"10.1038\/celldisc.2015.28","article-title":"Ubiquitin-specific protease 22 is a deubiquitinase of CCNB1","volume":"1","author":"Lin","year":"2015","journal-title":"Cell Discov."},{"key":"10.1016\/j.ymthe.2021.02.018_bib24","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/ncb3396","article-title":"Nuclear GSK3\u03b2 promotes tumorigenesis by phosphorylating KDM1A and inducing its deubiquitylation by USP22","volume":"18","author":"Zhou","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ymthe.2021.02.018_bib25","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.3892\/or.2014.3508","article-title":"Ubiquitin-specific protease 22-induced autophagy is correlated with poor prognosis of pancreatic cancer","volume":"32","author":"Liang","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ymthe.2021.02.018_bib26","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.3892\/ijo.2014.2531","article-title":"USP22 promotes the G1\/S phase transition by upregulating FoxM1 expression via \u03b2-catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinoma","volume":"45","author":"Ning","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ymthe.2021.02.018_bib27","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s00432-011-0998-9","article-title":"Elevated expression of USP22 in correlation with poor prognosis in patients with invasive breast cancer","volume":"137","author":"Zhang","year":"2011","journal-title":"J.\u00a0Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ymthe.2021.02.018_bib28","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/gutjnl-2019-319616","article-title":"USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1\u03b1\/USP22 positive feedback loop upon TP53 inactivation","volume":"69","author":"Ling","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.ymthe.2021.02.018_bib29","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1158\/2326-6066.CIR-18-0910","article-title":"USP22 Deubiquitinates CD274 to Suppress Anticancer Immunity","volume":"7","author":"Huang","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ymthe.2021.02.018_bib30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1359-6101(01)00038-7","article-title":"The roles of IFN gamma in protection against tumor development and cancer immunoediting","volume":"13","author":"Ikeda","year":"2002","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ymthe.2021.02.018_bib31","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2016.08.069","article-title":"Loss of IFN-\u03b3 Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy","volume":"167","author":"Gao","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2021.02.018_bib32","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1158\/1078-0432.CCR-13-2697","article-title":"T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with merkel cell carcinoma from healthy donors","volume":"20","author":"Lyngaa","year":"2014","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.ymthe.2021.02.018_bib33","first-page":"5047","article-title":"How Do Cytotoxic Lymphocytes Kill Cancer Cells? Clin","volume":"21","author":"Martinez-Lostao","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.ymthe.2021.02.018_bib34","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature17038","article-title":"Metastatic colonization by circulating tumour cells","volume":"529","author":"Massagu\u00e9","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.02.018_bib35","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.immuni.2019.06.017","article-title":"Treg Cells Promote the SREBP1-Dependent Metabolic Fitness of Tumor-Promoting Macrophages via Repression of CD8+ T Cell-Derived Interferon-\u03b3","volume":"51","author":"Liu","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2021.02.018_bib36","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41423-018-0021-3","article-title":"Distinct contribution of PD-L1 suppression by spatial expression of PD-L1 on tumor and non-tumor cells","volume":"16","author":"Zhang","year":"2019","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ymthe.2021.02.018_bib37","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nmeth.3047","article-title":"Improved vectors and genome-wide libraries for CRISPR screening","volume":"11","author":"Sanjana","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2021.02.018_bib38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1593\/neo.121572","article-title":"CD8+ tumor-infiltrating T\u00a0cells are trapped in the tumor-dendritic cell network","volume":"15","author":"Boissonnas","year":"2013","journal-title":"Neoplasia"},{"key":"10.1016\/j.ymthe.2021.02.018_bib39","doi-asserted-by":"crossref","first-page":"41679","DOI":"10.1074\/jbc.M406413200","article-title":"Alternative activation of STAT1 and STAT3 in response to interferon-gamma","volume":"279","author":"Qing","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2021.02.018_bib40","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","article-title":"Interferon-stimulated genes: a complex web of host defenses","volume":"32","author":"Schneider","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2021.02.018_bib41","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2021.02.018_bib42","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","article-title":"IFN\u03b3: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy","volume":"18","author":"Ivashkiv","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2021.02.018_bib43","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1172\/JCI85736","article-title":"Differential requirements for myeloid leukemia IFN-\u03b3 conditioning determine graft-versus-leukemia resistance and sensitivity","volume":"127","author":"Matte-Martone","year":"2017","journal-title":"J.\u00a0Clin. Invest."},{"issue":"Suppl 8","key":"10.1016\/j.ymthe.2021.02.018_bib44","first-page":"3","article-title":"Metabolism and action of fludarabine phosphate","volume":"17","author":"Plunkett","year":"1990","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.ymthe.2021.02.018_bib45","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/ni.2885","article-title":"USP15 stabilizes MDM2 to mediate cancer-cell survival and inhibit antitumor T\u00a0cell responses","volume":"15","author":"Zou","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2021.02.018_bib46","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1080\/15548627.2019.1635381","article-title":"The ubiquitin-specific protease USP8 directly deubiquitinates SQSTM1\/p62 to suppress its autophagic activity","volume":"16","author":"Peng","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.ymthe.2021.02.018_bib47","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fonc.2014.00088","article-title":"The Role of STAT1 for Crosstalk between Fibroblasts and Colon Cancer Cells","volume":"4","author":"Kaler","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ymthe.2021.02.018_bib48","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1083\/jcb.110.4.1211","article-title":"Histamine as a growth factor and chemoattractant for human carcinoma and melanoma cells: action through Ca2(+)-mobilizing H1 receptors","volume":"110","author":"Tilly","year":"1990","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.ymthe.2021.02.018_bib49","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/jnci\/88.9.590","article-title":"Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma","volume":"88","author":"Kunter","year":"1996","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.ymthe.2021.02.018_bib50","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/s41588-020-00727-5","article-title":"The critical roles of somatic mutations and environmental tumor-promoting agents in cancer risk","volume":"52","author":"Balmain","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2021.02.018_bib51","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nrc3006","article-title":"Transcriptional mutagenesis: causes and involvement in tumour development","volume":"11","author":"Br\u00e9geon","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ymthe.2021.02.018_bib52","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrc1016","article-title":"Cancer selection","volume":"3","author":"Leroi","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ymthe.2021.02.018_bib53","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2018.09.007","article-title":"Immune Checkpoint Inhibition Overcomes ADCP-Induced Immunosuppression by Macrophages","volume":"175","author":"Su","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2021.02.018_bib54","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response","volume":"560","author":"Chen","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.02.018_bib55","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm730","article-title":"Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion","volume":"8","author":"Dong","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2021.02.018_bib56","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1172\/JCI80011","article-title":"Anti-PD-1\/PD-L1 therapy of human cancer: past, present, and future","volume":"125","author":"Chen","year":"2015","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2021.02.018_bib57","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1158\/2159-8290.CD-16-1223","article-title":"Primary Resistance to PD-1 Blockade Mediated by JAK1\/2 Mutations","volume":"7","author":"Shin","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ymthe.2021.02.018_bib58","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature23477","article-title":"Identification of essential genes for cancer immunotherapy","volume":"548","author":"Patel","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.02.018_bib59","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41586-018-0615-z","article-title":"LILRB4 signalling in leukaemia cells mediates T\u00a0cell suppression and tumour infiltration","volume":"562","author":"Deng","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.02.018_bib60","doi-asserted-by":"crossref","first-page":"e20191174","DOI":"10.1084\/jem.20191174","article-title":"USP22 promotes IRF3 nuclear translocation and antiviral responses by deubiquitinating the importin protein KPNA2","volume":"217","author":"Cai","year":"2020","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ymthe.2021.02.018_bib61","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nature22311","article-title":"Tumour ischaemia by interferon-\u03b3 resembles physiological blood vessel regression","volume":"545","author":"Kammertoens","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.02.018_bib62","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nri3133","article-title":"Immunomodulatory functions of type I interferons","volume":"12","author":"Gonz\u00e1lez-Navajas","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2021.02.018_bib63","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ccr.2013.12.004","article-title":"Targeting the tumor microenvironment with interferon-\u03b2 bridges innate and adaptive immune responses","volume":"25","author":"Yang","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ymthe.2021.02.018_bib64","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-020-2746-2","article-title":"Functional genomic landscape of cancer-intrinsic evasion of killing by T\u00a0cells","volume":"586","author":"Lawson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.02.018_bib65","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41586-020-2099-x","article-title":"CRISPR screens in cancer spheroids identify 3D growth-specific vulnerabilities","volume":"580","author":"Han","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.02.018_bib66","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41588-019-0541-5","article-title":"ARID1A influences HDAC1\/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response","volume":"52","author":"Nagarajan","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2021.02.018_bib67","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.cell.2018.06.003","article-title":"Biology and Clinical Implications of the 19q13 Aggressive Prostate Cancer Susceptibility Locus","volume":"174","author":"Gao","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2021.02.018_bib68","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.cell.2018.03.052","article-title":"An Integrated Genome-wide CRISPRa Approach to Functionalize lncRNAs in Drug Resistance","volume":"173","author":"Bester","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2021.02.018_bib69","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.cell.2015.02.038","article-title":"Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis","volume":"160","author":"Chen","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2021.02.018_bib70","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.4049\/jimmunol.142.10.3714","article-title":"Tumor-specific cytolysis by lymphocytes infiltrating human melanomas","volume":"142","author":"Topalian","year":"1989","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2021.02.018_bib71","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.4049\/jimmunol.1300225","article-title":"Ubiquitin-specific protease 13 regulates IFN signaling by stabilizing STAT1","volume":"191","author":"Yeh","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2021.02.018_bib72","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cell.2008.10.051","article-title":"FAM\/USP9x, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination","volume":"136","author":"Dupont","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2021.02.018_bib73","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.celrep.2013.08.030","article-title":"The deubiquitinase USP28 stabilizes LSD1 and confers stem-cell-like traits to breast cancer cells","volume":"5","author":"Wu","year":"2013","journal-title":"Cell Rep."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162100085X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162100085X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:59:08Z","timestamp":1761501548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152500162100085X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":73,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S152500162100085X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2021.02.018","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"USP22 deficiency in melanoma mediates resistance to T\u00a0cells through IFN\u03b3-JAK1-STAT1 signal axis","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2021.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}